# Study of Sirolimus in Idiopathic Retroperitoneal Fibrosis

> **NCT04047576** · PHASE2,PHASE3 · RECRUITING · sponsor: **Peking University International Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Retroperitoneal Fibrosis

## Interventions

- **DRUG:** Sirolimus
- **DRUG:** Corticosteroid

## Key facts

- **NCT ID:** NCT04047576
- **Lead sponsor:** Peking University International Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-07-01
- **Primary completion:** 2025-12
- **Final completion:** 2026-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04047576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04047576, "Study of Sirolimus in Idiopathic Retroperitoneal Fibrosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04047576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*